Skip to main content
How strong is your knowledge on continuous glucose monitors? Take the quiz to test your expertise!
>
Agitation in Alzheimer Disease
Disease State Hub
Menu
Menu
Main navigation
Home
Education
Featured Topics
Acute Hepatic Porphyria
Agitation in Alzheimer Disease
COVID-19
Danon Disease
Depression Care 360
Diabetes
Endometrial Cancer
HIV Management
IgG4-Related Disease
Lupus Nephritis
MASH
Pain Management
Resources
Atlas of Lumps and Bumps
Case Presentations
Commentary
Disease State and Specialty Directory
FDA Alerts
Multidisciplinary Roundtables
Pearls
Podcasts
Polls
Q&A
Quizzes
Research Summaries
Slideshows
Videos
Featured Conferences
ACR Convergence
AIBD
American Society of Hematology Annual Meeting & Exposition
Consultant360's Practical Updates in Primary Care
Society of Hematologic Oncology's Annual Meeting
Clinical Updates
Allergic Asthma
Alzheimer Disease
Cardiovascular Disease
COVID-19
Endometrial Cancer
Endometrial Hyperplasia
Endometriosis
Eosinophilic Disorders
Exocrine Pancreatic Insufficiency
Generalized Pustular Psoriasis
Major Depressive Disorder
Nasal Polyps
Ovarian Cancer
Rheumatoid Arthritis
Schizophrenia
Ulcerative Colitis
Uterine Polyps
Publication
About Consultant
Advertising With Consultant360
Author Guidelines
Call for Papers
Case Report Templates
Consultant Current Issue
Consultant Archive
Consultant Early View
FAQ
Get Permissions
Get Permissions
Search
Contact
Login
Menu
Menu
Main navigation
Home
Education
Featured Topics
Acute Hepatic Porphyria
Agitation in Alzheimer Disease
COVID-19
Danon Disease
Depression Care 360
Diabetes
Endometrial Cancer
HIV Management
IgG4-Related Disease
Lupus Nephritis
MASH
Pain Management
Resources
Atlas of Lumps and Bumps
Case Presentations
Commentary
Disease State and Specialty Directory
FDA Alerts
Multidisciplinary Roundtables
Pearls
Podcasts
Polls
Q&A
Quizzes
Research Summaries
Slideshows
Videos
Featured Conferences
ACR Convergence
AIBD
American Society of Hematology Annual Meeting & Exposition
Consultant360's Practical Updates in Primary Care
Society of Hematologic Oncology's Annual Meeting
Clinical Updates
Allergic Asthma
Alzheimer Disease
Cardiovascular Disease
COVID-19
Endometrial Cancer
Endometrial Hyperplasia
Endometriosis
Eosinophilic Disorders
Exocrine Pancreatic Insufficiency
Generalized Pustular Psoriasis
Major Depressive Disorder
Nasal Polyps
Ovarian Cancer
Rheumatoid Arthritis
Schizophrenia
Ulcerative Colitis
Uterine Polyps
Publication
About Consultant
Advertising With Consultant360
Author Guidelines
Call for Papers
Case Report Templates
Consultant Current Issue
Consultant Archive
Consultant Early View
FAQ
Get Permissions
Get Permissions
Dronabinol Reduces Agitation in Patients With Alzheimer Disease
Anthony Calabro, MA
Copied to clipboard
In an interview with Consultant360, Paul B. Rosenberg, MD, discussed his team’s research on using dronabinol, a legal form of synthetic THC, to treat agitation in patients with Alzheimer disease. Prior to treatment, patients were tested for agitation using the Pittsburgh Agitation Scale and what other tool?
A. Neuropsychiatric Inventory Agitation/Aggression subscale
B. Richmond Agitation-Sedation Scale
C. Cohen-Mansfield Agitation Inventory
D. Riker Sedation Agitation Scale